nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxazepam—CYP3A7—Docetaxel—head and neck cancer	0.102	0.294	CbGbCtD
Oxazepam—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.102	0.294	CbGbCtD
Oxazepam—CYP3A5—Docetaxel—head and neck cancer	0.0763	0.221	CbGbCtD
Oxazepam—CYP3A4—Vinblastine—head and neck cancer	0.0361	0.104	CbGbCtD
Oxazepam—CYP3A4—Docetaxel—head and neck cancer	0.0298	0.0861	CbGbCtD
Oxazepam—Clonazepam—NAT2—head and neck cancer	0.0239	0.763	CrCbGaD
Oxazepam—Slurred speech—Fluorouracil—head and neck cancer	0.0189	0.076	CcSEcCtD
Oxazepam—Menstruation irregular—Docetaxel—head and neck cancer	0.011	0.0443	CcSEcCtD
Oxazepam—Disorientation—Hydroxyurea—head and neck cancer	0.00951	0.0383	CcSEcCtD
Oxazepam—Dysarthria—Fluorouracil—head and neck cancer	0.00892	0.0359	CcSEcCtD
Oxazepam—Euphoric mood—Fluorouracil—head and neck cancer	0.00725	0.0292	CcSEcCtD
Oxazepam—Disorientation—Fluorouracil—head and neck cancer	0.00684	0.0276	CcSEcCtD
Oxazepam—Agranulocytosis—Vinblastine—head and neck cancer	0.00671	0.027	CcSEcCtD
Oxazepam—Drowsiness—Hydroxyurea—head and neck cancer	0.00655	0.0264	CcSEcCtD
Oxazepam—Amnesia—Fluorouracil—head and neck cancer	0.00652	0.0263	CcSEcCtD
Oxazepam—Lethargy—Fluorouracil—head and neck cancer	0.00625	0.0252	CcSEcCtD
Oxazepam—Hallucination—Hydroxyurea—head and neck cancer	0.00585	0.0236	CcSEcCtD
Oxazepam—Ataxia—Fluorouracil—head and neck cancer	0.00576	0.0232	CcSEcCtD
Oxazepam—Vertigo—Vinblastine—head and neck cancer	0.00505	0.0203	CcSEcCtD
Oxazepam—Leukopenia—Vinblastine—head and neck cancer	0.00503	0.0203	CcSEcCtD
Oxazepam—Leukopenia—Hydroxyurea—head and neck cancer	0.00459	0.0185	CcSEcCtD
Oxazepam—Lethargy—Docetaxel—head and neck cancer	0.00451	0.0182	CcSEcCtD
Oxazepam—Agranulocytosis—Fluorouracil—head and neck cancer	0.0044	0.0177	CcSEcCtD
Oxazepam—Oedema—Hydroxyurea—head and neck cancer	0.00418	0.0168	CcSEcCtD
Oxazepam—Ataxia—Docetaxel—head and neck cancer	0.00416	0.0167	CcSEcCtD
Oxazepam—Paraesthesia—Vinblastine—head and neck cancer	0.00412	0.0166	CcSEcCtD
Oxazepam—Flurbiprofen—PTGS2—head and neck cancer	0.00397	0.127	CrCbGaD
Oxazepam—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00375	0.0151	CcSEcCtD
Oxazepam—Somnolence—Hydroxyurea—head and neck cancer	0.00372	0.015	CcSEcCtD
Oxazepam—Abdominal pain—Vinblastine—head and neck cancer	0.00362	0.0146	CcSEcCtD
Oxazepam—Vision blurred—Fluorouracil—head and neck cancer	0.00347	0.014	CcSEcCtD
Oxazepam—Clozapine—CYP1A1—head and neck cancer	0.00342	0.109	CrCbGaD
Oxazepam—Hypersensitivity—Vinblastine—head and neck cancer	0.00338	0.0136	CcSEcCtD
Oxazepam—Jaundice—Docetaxel—head and neck cancer	0.00332	0.0134	CcSEcCtD
Oxazepam—Body temperature increased—Hydroxyurea—head and neck cancer	0.0033	0.0133	CcSEcCtD
Oxazepam—Leukopenia—Fluorouracil—head and neck cancer	0.0033	0.0133	CcSEcCtD
Oxazepam—Agranulocytosis—Docetaxel—head and neck cancer	0.00318	0.0128	CcSEcCtD
Oxazepam—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00308	0.0124	CcSEcCtD
Oxazepam—Dizziness—Vinblastine—head and neck cancer	0.00303	0.0122	CcSEcCtD
Oxazepam—Oedema—Fluorouracil—head and neck cancer	0.00301	0.0121	CcSEcCtD
Oxazepam—Headache—Vinblastine—head and neck cancer	0.00287	0.0116	CcSEcCtD
Oxazepam—Hypotension—Fluorouracil—head and neck cancer	0.00281	0.0113	CcSEcCtD
Oxazepam—Dizziness—Hydroxyurea—head and neck cancer	0.00276	0.0111	CcSEcCtD
Oxazepam—Nausea—Vinblastine—head and neck cancer	0.00272	0.011	CcSEcCtD
Oxazepam—Paraesthesia—Fluorouracil—head and neck cancer	0.0027	0.0109	CcSEcCtD
Oxazepam—Somnolence—Fluorouracil—head and neck cancer	0.00268	0.0108	CcSEcCtD
Oxazepam—Rash—Hydroxyurea—head and neck cancer	0.00264	0.0106	CcSEcCtD
Oxazepam—Dermatitis—Hydroxyurea—head and neck cancer	0.00263	0.0106	CcSEcCtD
Oxazepam—Headache—Hydroxyurea—head and neck cancer	0.00262	0.0106	CcSEcCtD
Oxazepam—Nausea—Hydroxyurea—head and neck cancer	0.00248	0.01	CcSEcCtD
Oxazepam—Syncope—Docetaxel—head and neck cancer	0.00239	0.00962	CcSEcCtD
Oxazepam—Leukopenia—Docetaxel—head and neck cancer	0.00238	0.0096	CcSEcCtD
Oxazepam—Body temperature increased—Fluorouracil—head and neck cancer	0.00238	0.00959	CcSEcCtD
Oxazepam—Loss of consciousness—Docetaxel—head and neck cancer	0.00234	0.00943	CcSEcCtD
Oxazepam—Hypersensitivity—Fluorouracil—head and neck cancer	0.00222	0.00894	CcSEcCtD
Oxazepam—Oedema—Docetaxel—head and neck cancer	0.00217	0.00875	CcSEcCtD
Oxazepam—Shock—Docetaxel—head and neck cancer	0.00214	0.00861	CcSEcCtD
Oxazepam—CYP3A43—Metapathway biotransformation—GSTM1—head and neck cancer	0.00206	0.00549	CbGpPWpGaD
Oxazepam—Hypotension—Docetaxel—head and neck cancer	0.00203	0.00818	CcSEcCtD
Oxazepam—UGT1A9—Biological oxidations—NAT2—head and neck cancer	0.00202	0.0054	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—NAT2—head and neck cancer	0.002	0.00533	CbGpPWpGaD
Oxazepam—Dizziness—Fluorouracil—head and neck cancer	0.00199	0.00802	CcSEcCtD
Oxazepam—CYP3A43—Biological oxidations—CYP1A1—head and neck cancer	0.00198	0.00528	CbGpPWpGaD
Oxazepam—UGT1A9—NRF2 pathway—TGFA—head and neck cancer	0.00196	0.00523	CbGpPWpGaD
Oxazepam—CYP3A43—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00195	0.00521	CbGpPWpGaD
Oxazepam—Paraesthesia—Docetaxel—head and neck cancer	0.00195	0.00786	CcSEcCtD
Oxazepam—Somnolence—Docetaxel—head and neck cancer	0.00193	0.00778	CcSEcCtD
Oxazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00191	0.00511	CbGpPWpGaD
Oxazepam—Rash—Fluorouracil—head and neck cancer	0.0019	0.00765	CcSEcCtD
Oxazepam—Dermatitis—Fluorouracil—head and neck cancer	0.0019	0.00764	CcSEcCtD
Oxazepam—Headache—Fluorouracil—head and neck cancer	0.00189	0.0076	CcSEcCtD
Oxazepam—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00185	0.00494	CbGpPWpGaD
Oxazepam—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00183	0.00487	CbGpPWpGaD
Oxazepam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00179	0.00478	CbGpPWpGaD
Oxazepam—Nausea—Fluorouracil—head and neck cancer	0.00179	0.0072	CcSEcCtD
Oxazepam—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00178	0.00716	CcSEcCtD
Oxazepam—CYP3A43—Metabolism—UROD—head and neck cancer	0.00174	0.00464	CbGpPWpGaD
Oxazepam—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00172	0.00459	CbGpPWpGaD
Oxazepam—Abdominal pain—Docetaxel—head and neck cancer	0.00172	0.00692	CcSEcCtD
Oxazepam—Body temperature increased—Docetaxel—head and neck cancer	0.00172	0.00692	CcSEcCtD
Oxazepam—UGT1A9—Phase II conjugation—GSTM1—head and neck cancer	0.00171	0.00456	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—NAT2—head and neck cancer	0.0017	0.00454	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—NAT2—head and neck cancer	0.00168	0.00448	CbGpPWpGaD
Oxazepam—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.00163	0.00435	CbGpPWpGaD
Oxazepam—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.00162	0.00433	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00162	0.00432	CbGpPWpGaD
Oxazepam—Hypersensitivity—Docetaxel—head and neck cancer	0.0016	0.00645	CcSEcCtD
Oxazepam—GABRR2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00154	0.00412	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00154	0.00412	CbGpPWpGaD
Oxazepam—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.0015	0.004	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.0015	0.004	CbGpPWpGaD
Oxazepam—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.0015	0.004	CbGpPWpGaD
Oxazepam—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00144	0.00384	CbGpPWpGaD
Oxazepam—Dizziness—Docetaxel—head and neck cancer	0.00144	0.00579	CcSEcCtD
Oxazepam—UGT2B7—NRF2 pathway—GSTM1—head and neck cancer	0.0014	0.00374	CbGpPWpGaD
Oxazepam—Rash—Docetaxel—head and neck cancer	0.00137	0.00552	CcSEcCtD
Oxazepam—Dermatitis—Docetaxel—head and neck cancer	0.00137	0.00551	CcSEcCtD
Oxazepam—Headache—Docetaxel—head and neck cancer	0.00136	0.00548	CcSEcCtD
Oxazepam—UGT1A9—PPARA activates gene expression—CYP1A1—head and neck cancer	0.00136	0.00361	CbGpPWpGaD
Oxazepam—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00134	0.00357	CbGpPWpGaD
Oxazepam—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—head and neck cancer	0.00133	0.00354	CbGpPWpGaD
Oxazepam—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00132	0.00352	CbGpPWpGaD
Oxazepam—Nausea—Docetaxel—head and neck cancer	0.00129	0.0052	CcSEcCtD
Oxazepam—GABRG3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00127	0.00339	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00125	0.00334	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—NAT2—head and neck cancer	0.00123	0.00328	CbGpPWpGaD
Oxazepam—UGT2B7—Biological oxidations—GSTM1—head and neck cancer	0.00123	0.00328	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	0.00121	0.00324	CbGpPWpGaD
Oxazepam—UGT2B7—Metapathway biotransformation—GSTM1—head and neck cancer	0.00121	0.00324	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00118	0.00316	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00117	0.00312	CbGpPWpGaD
Oxazepam—UGT2B7—Biological oxidations—CYP1A1—head and neck cancer	0.00117	0.00311	CbGpPWpGaD
Oxazepam—UGT2B7—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00115	0.00307	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.00115	0.00306	CbGpPWpGaD
Oxazepam—UGT1A9—NRF2 pathway—GSTM1—head and neck cancer	0.00114	0.00304	CbGpPWpGaD
Oxazepam—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00108	0.00289	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00107	0.00285	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00104	0.00277	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—UROD—head and neck cancer	0.00103	0.00274	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00102	0.00272	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.001	0.00268	CbGpPWpGaD
Oxazepam—UGT1A9—Biological oxidations—GSTM1—head and neck cancer	0.001	0.00267	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000996	0.00266	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000986	0.00263	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000978	0.00261	CbGpPWpGaD
Oxazepam—UGT1A9—Biological oxidations—CYP1A1—head and neck cancer	0.000948	0.00253	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—NAT2—head and neck cancer	0.000935	0.00249	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000935	0.00249	CbGpPWpGaD
Oxazepam—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.000914	0.00244	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000855	0.00228	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	0.000841	0.00224	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—UROD—head and neck cancer	0.000834	0.00222	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	0.000829	0.00221	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—DPYD—head and neck cancer	0.00082	0.00219	CbGpPWpGaD
Oxazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000815	0.00217	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	0.000797	0.00213	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000786	0.0021	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—YAP1—head and neck cancer	0.000778	0.00208	CbGpPWpGaD
Oxazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000778	0.00207	CbGpPWpGaD
Oxazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000778	0.00207	CbGpPWpGaD
Oxazepam—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000769	0.00205	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—NAT2—head and neck cancer	0.000723	0.00193	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—UROD—head and neck cancer	0.000701	0.00187	CbGpPWpGaD
Oxazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000655	0.00175	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000647	0.00173	CbGpPWpGaD
Oxazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.00064	0.00171	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—DPYD—head and neck cancer	0.000634	0.00169	CbGpPWpGaD
Oxazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000631	0.00168	CbGpPWpGaD
Oxazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000624	0.00167	CbGpPWpGaD
Oxazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000624	0.00167	CbGpPWpGaD
Oxazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000622	0.00166	CbGpPWpGaD
Oxazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000614	0.00164	CbGpPWpGaD
Oxazepam—GABRR1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000613	0.00163	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.000608	0.00162	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—YAP1—head and neck cancer	0.000602	0.0016	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.0006	0.0016	CbGpPWpGaD
Oxazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000597	0.00159	CbGpPWpGaD
Oxazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000589	0.00157	CbGpPWpGaD
Oxazepam—GABRR2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000585	0.00156	CbGpPWpGaD
Oxazepam—GABRQ—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000585	0.00156	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	0.000576	0.00154	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000572	0.00153	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000568	0.00152	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000564	0.00151	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—STAT3—head and neck cancer	0.00054	0.00144	CbGpPWpGaD
Oxazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000539	0.00144	CbGpPWpGaD
Oxazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000524	0.0014	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—MAPK3—head and neck cancer	0.000516	0.00138	CbGpPWpGaD
Oxazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000514	0.00137	CbGpPWpGaD
Oxazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000514	0.00137	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—UROD—head and neck cancer	0.000507	0.00135	CbGpPWpGaD
Oxazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000506	0.00135	CbGpPWpGaD
Oxazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000505	0.00135	CbGpPWpGaD
Oxazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000504	0.00135	CbGpPWpGaD
Oxazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000502	0.00134	CbGpPWpGaD
Oxazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000493	0.00132	CbGpPWpGaD
Oxazepam—GABRR1—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000492	0.00131	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—MAPK1—head and neck cancer	0.000491	0.00131	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000481	0.00128	CbGpPWpGaD
Oxazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000479	0.00128	CbGpPWpGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000474	0.00126	CbGpPWpGaD
Oxazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000473	0.00126	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—MAPK1—head and neck cancer	0.00047	0.00125	CbGpPWpGaD
Oxazepam—GABRR2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000469	0.00125	CbGpPWpGaD
Oxazepam—GABRQ—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000469	0.00125	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—TYMS—head and neck cancer	0.000467	0.00125	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GSTM1—head and neck cancer	0.000462	0.00123	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000449	0.0012	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—MAPK1—head and neck cancer	0.000448	0.00119	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—MAPK1—head and neck cancer	0.000448	0.00119	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000443	0.00118	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GPX1—head and neck cancer	0.000442	0.00118	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000439	0.00117	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CYP1A1—head and neck cancer	0.000438	0.00117	CbGpPWpGaD
Oxazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000433	0.00115	CbGpPWpGaD
Oxazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000431	0.00115	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—NAT2—head and neck cancer	0.000426	0.00114	CbGpPWpGaD
Oxazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.00042	0.00112	CbGpPWpGaD
Oxazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000413	0.0011	CbGpPWpGaD
Oxazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000406	0.00108	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000405	0.00108	CbGpPWpGaD
Oxazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000403	0.00108	CbGpPWpGaD
Oxazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000396	0.00106	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—HRAS—head and neck cancer	0.000394	0.00105	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000394	0.00105	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000387	0.00103	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000387	0.00103	CbGpPWpGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000381	0.00102	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.00038	0.00101	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000377	0.00101	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—HRAS—head and neck cancer	0.000377	0.00101	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—DPYD—head and neck cancer	0.000374	0.000996	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000371	0.000989	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—MAPK1—head and neck cancer	0.000369	0.000984	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000368	0.000981	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000364	0.000971	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—MAPK1—head and neck cancer	0.000363	0.000969	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—TYMS—head and neck cancer	0.000361	0.000963	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.00036	0.000961	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—HRAS—head and neck cancer	0.00036	0.000959	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—HRAS—head and neck cancer	0.00036	0.000959	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GSTM1—head and neck cancer	0.000357	0.000952	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000356	0.000949	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—YAP1—head and neck cancer	0.000355	0.000946	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—AKT1—head and neck cancer	0.000348	0.000928	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—NAT2—head and neck cancer	0.000346	0.000923	CbGpPWpGaD
Oxazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000346	0.000923	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—MAPK1—head and neck cancer	0.000344	0.000917	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GPX1—head and neck cancer	0.000342	0.000912	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—MAPK1—head and neck cancer	0.00034	0.000905	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CYP1A1—head and neck cancer	0.000338	0.000903	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000325	0.000868	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000324	0.000864	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000316	0.000843	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—MAPK1—head and neck cancer	0.000311	0.000828	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.00031	0.000828	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000305	0.000814	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—DPYD—head and neck cancer	0.000304	0.00081	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000303	0.000808	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—MAPK1—head and neck cancer	0.000302	0.000805	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000298	0.000794	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—MAPK1—head and neck cancer	0.000296	0.00079	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—HRAS—head and neck cancer	0.000296	0.00079	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—HRAS—head and neck cancer	0.000292	0.000778	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—NAT2—head and neck cancer	0.000291	0.000777	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—MAPK1—head and neck cancer	0.000291	0.000776	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—MAPK1—head and neck cancer	0.000289	0.000771	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—YAP1—head and neck cancer	0.000288	0.000768	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—MAPK1—head and neck cancer	0.000284	0.000757	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000283	0.000754	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000279	0.000743	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—HRAS—head and neck cancer	0.000276	0.000736	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—HRAS—head and neck cancer	0.000273	0.000727	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000268	0.000715	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000264	0.000705	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PTGS2—head and neck cancer	0.00026	0.000695	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.00026	0.000694	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—DPYD—head and neck cancer	0.000255	0.000681	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—HRAS—head and neck cancer	0.000249	0.000665	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—MAPK1—head and neck cancer	0.000248	0.000662	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—YAP1—head and neck cancer	0.000242	0.000646	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—HRAS—head and neck cancer	0.000242	0.000646	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—HRAS—head and neck cancer	0.000238	0.000634	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—UROD—head and neck cancer	0.000236	0.000628	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—HRAS—head and neck cancer	0.000234	0.000623	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—HRAS—head and neck cancer	0.000232	0.000619	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—HRAS—head and neck cancer	0.000228	0.000608	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PTEN—head and neck cancer	0.000227	0.000606	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000216	0.000577	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—TYMS—head and neck cancer	0.000213	0.000568	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—NAT2—head and neck cancer	0.00021	0.000561	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GSTM1—head and neck cancer	0.00021	0.000561	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GPX1—head and neck cancer	0.000202	0.000537	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PTGS2—head and neck cancer	0.000201	0.000537	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CYP1A1—head and neck cancer	0.000199	0.000532	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—HRAS—head and neck cancer	0.000199	0.000532	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000189	0.000503	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—DPYD—head and neck cancer	0.000185	0.000492	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PTEN—head and neck cancer	0.000176	0.000468	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—YAP1—head and neck cancer	0.000175	0.000467	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—TYMS—head and neck cancer	0.000173	0.000461	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GSTM1—head and neck cancer	0.000171	0.000456	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GPX1—head and neck cancer	0.000164	0.000437	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CYP1A1—head and neck cancer	0.000162	0.000432	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PIK3CA—head and neck cancer	0.00016	0.000427	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—TYMS—head and neck cancer	0.000145	0.000388	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GSTM1—head and neck cancer	0.000144	0.000384	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GPX1—head and neck cancer	0.000138	0.000367	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CYP1A1—head and neck cancer	0.000136	0.000364	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000133	0.000355	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—AKT1—head and neck cancer	0.000131	0.000349	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PIK3CA—head and neck cancer	0.000124	0.00033	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PTGS2—head and neck cancer	0.000119	0.000316	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—TYMS—head and neck cancer	0.000105	0.00028	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GSTM1—head and neck cancer	0.000104	0.000277	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PTEN—head and neck cancer	0.000103	0.000276	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—AKT1—head and neck cancer	0.000101	0.00027	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GPX1—head and neck cancer	9.95e-05	0.000266	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CYP1A1—head and neck cancer	9.85e-05	0.000263	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—NAT2—head and neck cancer	9.79e-05	0.000261	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PTGS2—head and neck cancer	9.64e-05	0.000257	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—DPYD—head and neck cancer	8.58e-05	0.000229	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PTEN—head and neck cancer	8.41e-05	0.000224	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—YAP1—head and neck cancer	8.14e-05	0.000217	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PTGS2—head and neck cancer	8.11e-05	0.000216	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PIK3CA—head and neck cancer	7.3e-05	0.000195	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PTEN—head and neck cancer	7.07e-05	0.000189	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—AKT1—head and neck cancer	5.96e-05	0.000159	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PIK3CA—head and neck cancer	5.93e-05	0.000158	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PTGS2—head and neck cancer	5.86e-05	0.000156	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PTEN—head and neck cancer	5.11e-05	0.000136	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PIK3CA—head and neck cancer	4.99e-05	0.000133	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—TYMS—head and neck cancer	4.89e-05	0.00013	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—AKT1—head and neck cancer	4.84e-05	0.000129	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.83e-05	0.000129	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GPX1—head and neck cancer	4.63e-05	0.000123	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CYP1A1—head and neck cancer	4.58e-05	0.000122	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—AKT1—head and neck cancer	4.07e-05	0.000109	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PIK3CA—head and neck cancer	3.61e-05	9.62e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—AKT1—head and neck cancer	2.95e-05	7.86e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.72e-05	7.27e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PTEN—head and neck cancer	2.38e-05	6.34e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.68e-05	4.47e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—AKT1—head and neck cancer	1.37e-05	3.65e-05	CbGpPWpGaD
